VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
VenoStent has raised $4.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
VenoStent's investors include National Science Foundation, Norwest Venture Partners, Y Combinator, Alumni Ventures, Good Growth Capital.
VenoStent is headquartered in Houston, United States.
VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.
VenoStent is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VenoStent — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/venostent. Accessed July 21, 2026.
VCBacked. (2024). VenoStent — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/venostent
{{cite web |title=VenoStent — Funding & Investors |url=https://www.vcbacked.co/company/venostent |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated